SCHEMBL1640478

SCHEMBL1640478

CC(=O)OCCc1ccc(C(=O)CCC(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.64
KMT2A Q03164 1/20 0.53
HSD17B10 Q99714 2/20 0.49
USP5 P45974 1/20 0.49
NR4A2 P43354 1/20 0.49
RAB9A P51151 2/20 0.47
CYP1A2 P05177 2/20 0.47
FFAR1 O14842 2/20 0.47
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP2C19 P33261 2/20 0.45
GAA P10253 1/20 0.45
CYP2J2 P51589 1/20 0.43
HPGD P15428 1/20 0.43
PDE4B Q07343 1/20 0.43
MMP2 P08253 1/20 0.42
MMP12 P39900 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168852 0.81 GSK3B (0.50) L3MBTL1RAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL8501592 0.81 THRA (0.57)
SCHEMBL4293988 0.81 THRA (0.57)
SCHEMBL86418 0.80 KMT2A (0.55) L3MBTL1KMT2AHSD17B10RAB9ALMNA
Phenyl Propionic Acid SCHEMBL29974596 0.79 KEAP1 (0.66) FFAR1SMN1; SMN2ALDH1A1
SCHEMBL4265689 0.78 L3MBTL1 (1.00) L3MBTL1KMT2AHSD17B10USP5NR4A2
SCHEMBL5742746 0.78 RAB9A (0.41) L3MBTL1RAB9ALMNASMN1; SMN2NPC1
SCHEMBL31512079 0.76 L3MBTL1 (0.71) L3MBTL1KMT2AHSD17B10USP5NR4A2
SCHEMBL12064824 0.76 L3MBTL1 (0.71) L3MBTL1KMT2AUSP5NR4A2RAB9A
Phenylbutanoic Acid SCHEMBL29411188 0.76 HDAC3 (0.68) HSD17B10RAB9ACYP1A2FFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328586-A2 SUBSTITUTED PYRIDAZINONE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS Cephalon, Inc. (US) 2011-06-08 EP disclosed
US-20110098269-A1 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands CEPHALON, INC. (US) 2011-04-28 US disclosed
WO-2009142732-A2 SUBSTITUTED PYRIDAZINONE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS CEPHALON, INC. (US) 2009-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098269-A1 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands HRH3, HRH4, HRH2 L3MBTL1 4816/4885KMT2A 923/4885HSD17B10 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.